Physician

Paul Revis, M.D.

According to 2025 Medicare claims, Paul Revis, M.D. (NPI: 1518984293) practices dermatology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is PAUL REVIS MD SC (NPI: 1952505422; TIN: 770673400) and primary practice location at 61107-5904.

Revis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,002 traditional Medicare patients, billed 4,113 HCPCS/CPT codes, and received $198,653 in Medicare payments. The top billing code was 11104 (Punch biopsy, first skin growth). Part D data shows 2,050 prescription claims across 865 beneficiaries totaling $761,576 in drug costs, led by Otezla (Apremilast). Open Payments data shows 2 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $326,806 to $761,576. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,571	7,818	$296,427
2016	1,460	7,328	$275,077
2017	1,523	7,651	$282,760
2018	1,431	7,318	$281,481
2019	1,373	7,108	$283,044
2020	1,216	5,546	$245,621
2021	1,238	5,839	$274,424
2022	1,200	5,007	$228,906
2023	1,133	5,080	$243,766
2024	1,002	4,113	$198,653

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	596	1,520	$326,806
2016	652	1,573	$406,242
2017	643	1,468	$399,668
2018	660	1,507	$375,544
2019	694	1,615	$500,688
2020	672	1,511	$426,976
2021	718	1,522	$524,668
2022	739	1,804	$701,308
2023	866	2,059	$1,000,600
2024	865	2,050	$761,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11104	Punch biopsy, first skin growth	207	230	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	514	646	$63
17000	Destruction of precancer skin growth, 1 growth	315	360	$38
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	261	302	$38
17003	Destruction of precancer skin growth, 2-14 growths	243	1,325	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	45	1,470	$241,246
Humira(Cf) Pen	Adalimumab	20	574	$136,418
Taltz Autoinjector	Ixekizumab	13	364	$87,466
Dupixent Pen	Dupilumab	19	518	$68,444
Fluorouracil	Fluorouracil	209	6,155	$15,051

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$31	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Revis, M.D.?

Tedicare shows public-source Medicare data for Paul Revis, M.D. (NPI 1518984293), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Revis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Revis, M.D.?

Paul Revis, M.D. is linked to PAUL REVIS MD SC (billing NPI 1952505422) in the available physician profile data.

Does Paul Revis, M.D. have Open Payments data?

Paul Revis, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.